相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。BrevicidineB, a New Member of the Brevicidine Family, Displays an Extended Target Specificity
Xinghong Zhao et al.
FRONTIERS IN MICROBIOLOGY (2021)
Development of a novel hybrid antimicrobial peptide for targeted killing of Pseudomonas aeruginosa
Hyun Kim et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
An Engineered Double Lipid II Binding Motifs-Containing Lantibiotic Displays Potent and Selective Antimicrobial Activity against Enterococcus faecium
Xinghong Zhao et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
High-Throughput Screening for Substrate Specificity-Adapted Mutants of the Nisin Dehydratase NisB
Xinghong Zhao et al.
ACS SYNTHETIC BIOLOGY (2020)
Subcellular Localization and Assembly Process of the Nisin Biosynthesis Machinery in Lactococcus lactis
Jingqi Chen et al.
MBIO (2020)
Mimicry of a Non-ribosomally Produced Antimicrobial, Brevicidine, by Ribosomal Synthesis and Post-translational Modification
Xinghong Zhao et al.
CELL CHEMICAL BIOLOGY (2020)
Analysis of modular bioengineered antimicrobial lanthipeptides at nanoliter scale
Steven Schmitt et al.
NATURE CHEMICAL BIOLOGY (2019)
Bypassing lantibiotic resistance by an effective nisin derivative
Julia Zaschke-Kriesche et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2019)
Current developments in lantibiotic discovery for treating Clostridium difficile infection
Stephanie Kate Sandiford
EXPERT OPINION ON DRUG DISCOVERY (2019)
Expanding the potential of NAI-107 for treating serious ESKAPE pathogens: synergistic combinations against Gram-negatives and bactericidal activity against non-dividing cells
Cristina Brunati et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
The roles of antimicrobial peptide, rip-thanatin, in the midgut of &ITRiptortus pedestris&IT
Kyoung-Eun Park et al.
DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY (2018)
Increasing the Antimicrobial Activity of Nisin-Based Lantibiotics against Gram-Negative Pathogens
Qian Li et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2018)
Thanatin targets the intermembrane protein complex required for lipopolysaccharide transport in Escherichia coli
Stefan U. Vetterli et al.
SCIENCE ADVANCES (2018)
High Specific Selectivity and Membrane-Active Mechanism of Synthetic Cationic Hybrid Antimicrobial Peptides Based on the Peptide FV7
Tingting Tan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Employing the promiscuity of lantibiotic biosynthetic machineries to produce novel antimicrobials
Manuel Montalban-Lopez et al.
FEMS MICROBIOLOGY REVIEWS (2017)
Mechanistic Understanding of Lanthipeptide Biosynthetic Enzymes
Lindsay M. Repka et al.
CHEMICAL REVIEWS (2017)
Pharmacological and pharmacokinetic properties of lanthipeptides undergoing clinical studies
Elvis Legala Ongey et al.
BIOTECHNOLOGY LETTERS (2017)
Structural basis of lantibiotic recognition by the nisin resistance protein from Streptococcus agalactiae
Sakshi Khosa et al.
SCIENTIFIC REPORTS (2016)
Discovery, Production and Modification of Five Novel Lantibiotics Using the Promiscuous Nisin Modification Machinery
Auke J. van Heel et al.
ACS SYNTHETIC BIOLOGY (2016)
Perspectives on lantibiotic discovery - where have we failed and what improvements are required?
Stephanie Kate Sandiford
EXPERT OPINION ON DRUG DISCOVERY (2015)
A new antibiotic kills pathogens without detectable resistance
Losee L. Ling et al.
NATURE (2015)
Bioengineering Lantibiotics for Therapeutic Success
Des Field et al.
FRONTIERS IN MICROBIOLOGY (2015)
Site-Directed Mutations in the Lanthipeptide Mutacin 1140
Shaorong Chen et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2013)
Scalable purification of the lantibiotic nisin and isolation of chemical/enzymatic cleavage fragments suitable for semi-synthesis
Jack C. Slootweg et al.
JOURNAL OF PEPTIDE SCIENCE (2013)
Designing and Producing Modified, New-to-Nature Peptides with Antimicrobial Activity by Use of a Combination of Various Lantibiotic Modification Enzymes
Auke J. van Heel et al.
ACS SYNTHETIC BIOLOGY (2013)
New horizons for host defense peptides and lantibiotics
Michael John Dawson et al.
CURRENT OPINION IN PHARMACOLOGY (2012)
Efficacy of the New Lantibiotic NAI-107 in Experimental Infections Induced by Multidrug-Resistant Gram-Positive Pathogens
Daniela Jabes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Activity and Export of Engineered Nisin-(1-22) Analogs
Annechien Plat et al.
POLYMERS (2011)
Bioengineering of a Nisin A-producing Lactococcus lactis to create isogenic strains producing the natural variants Nisin F, Q and Z
Clare Piper et al.
MICROBIAL BIOTECHNOLOGY (2011)
In Vitro Double and Triple Bactericidal Activities of Doripenem, Polymyxin B, and Rifampin against Multidrug-Resistant Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli
Carl Urban et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Studies with bioengineered Nisin peptides highlight the broad-spectrum potency of Nisin V
Des Field et al.
MICROBIAL BIOTECHNOLOGY (2010)
Activity of the Antimicrobial Peptide and Thanatin Analog S-thanatin on Clinical Isolates of Klebsiella pneumoniae Resistant to Conventional Antibiotics with Different Structures
Guo-Qiu Wu et al.
CURRENT MICROBIOLOGY (2009)
The generation of nisin variants with enhanced activity against specific Gram-positive pathogens
Des Field et al.
MOLECULAR MICROBIOLOGY (2008)
Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances
Irith Wiegand et al.
NATURE PROTOCOLS (2008)
An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II
Hester E. Hasper et al.
SCIENCE (2006)
Lipid II as a target for antibiotics
E Breukink et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Optimization and applications of CDAP labeling for the assignment of cysteines
GD Pipes et al.
PHARMACEUTICAL RESEARCH (2005)
Lantibiotic structures as guidelines for the design of peptides that can be modified by lantibiotic enzymes
R Rink et al.
BIOCHEMISTRY (2005)
Antimicrobial peptides: New candidates in the fight against bacterial infections
O Toke
BIOPOLYMERS (2005)
Antimicrobial peptides in animals and their role in host defences
KA Brogden et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2003)
Thanatin activity on multidrug resistant clinical isolates of Enterobacter aerogenes and Klebsiella pneumoniae
JM Pagès et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2003)
Lipid II is an intrinsic component of the pore induced by nisin in bacterial membranes
E Breukink et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
分享论文
